Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yoshimasa Hamano"'
Autor:
Toru Arai, Masaki Hirose, Yoshimasa Hamano, Tomoko Kagawa, Akihiro Murakami, Hiroshi Kida, Atsushi Kumanogoh, Yoshikazu Inoue
Publikováno v:
Canadian Respiratory Journal, Vol 2022 (2022)
Background. We have previously analysed serum autoantibody levels in patients with idiopathic pulmonary fibrosis (IPF), idiopathic nonspecific interstitial pneumonia (iNSIP), and healthy controls and identified the autoantibody against anti-myxovirus
Externí odkaz:
https://doaj.org/article/399ed16bea414b94b3e41a22fda9dec8
Autor:
Yasuhiro Kato, Kenji Mizuguchi, Masanori Kitaichi, Yoshikazu Inoue, Toshimitsu Hamasaki, Koji Inoue, Masahiro Yanagawa, Tetsuya Kimura, Toshiyuki Minami, Akihiro Murakami, Shoichi Ihara, Izumi Nagatomo, Yoshito Takeda, Yoshimasa Hamano, Haruhiko Hirata, Hiroshi Kida, Masaki Hirose, Masahide Mori, Hyota Takamatsu, Osamu Honda, Yukihiro Yano, Toru Arai, Noriyuki Tomiyama, Tomoyuki Otsuka, Ken Ueda, Hiroyoshi Nishikawa, Lokesh P. Tripathi, Takashi Kijima, Atsushi Kumanogoh
Publikováno v:
Scientific Reports
Chronic fibrosing idiopathic interstitial pneumonia (IIP) can be divided into two main types: idiopathic pulmonary fibrosis (IPF), a steroid-resistant and progressive disease with a median survival of 2–3 years, and idiopathic non-specific intersti
Autor:
Yasunori Shimaoka, M. Fusama, Kayoko Higashi, Takashi Hosokawa, Keisuke Kawamoto, Masao Yukioka, Yasushi Miura, Yoshimasa Hamano, Keiji Maeda, Takanori Kuroiwa, Satoko Nozato, Shinji Higa, Masayuki Nishide, Tsuyoshi Igarashi, Eiji Takeuchi, Taro Kuritani, H. Nakahara
Publikováno v:
Modern Rheumatology. 23:276-283
To evaluate the improvement of health status in patients with rheumatoid arthritis (RA) treated with tocilizumab. Thirty-nine patients were treated with 8 mg/kg tocilizumab every 4 weeks for 24 weeks. Disease activity was assessed by Clinical Disease
Autor:
Taro Kuritani, Masayuki Nishide, H. Nakahara, Yu Lin, Keisuke Kawamoto, Yosuke Kamide, M. Fusama, Shinji Higa, Takashi Hosokawa, Tsuyoshi Igarashi, Takashi Kuroiwa, Yoshimasa Hamano, Keiji Maeda
Publikováno v:
Modern Rheumatology. 21:655-659
Autor:
Keisuke Kawamoto, Yu Lin, Taro Kuritani, H. Nakahara, M. Fusama, Takashi Kuroiwa, Yoshimasa Hamano, Takashi Hosokawa, Keiji Maeda, Tsuyoshi Igarashi, Shinji Higa, Yosuke Kamide, Masayuki Nishide
Publikováno v:
Modern Rheumatology. 21:655-659
A female patient with rheumatoid arthritis (RA) suffered from Mycobacterium avium (M. avium) infection during tocilizumab treatment. Tocilizumab was discontinued and she was treated with a recommended chemotherapy, resulting in improvement of M. aviu
Autor:
Shunji Miki, Norihiro Nishimoto, Yoshimasa Hamano, Nobuyuki Asanuma, Masaki Suemura, Hiroshi Fujiwara, Soji Kasayama
Publikováno v:
Modern Rheumatology. 19:64-68
Although reports of serious infections in clinical trials for rheumatoid arthritis (RA) with tocilizumab, anti-interleukin6 (IL-6) receptor antibody, have been relatively few, there is still some concern about infections. We report here two cases of
Publikováno v:
Journal of Chromatography A. 332:275-282
Analytical conditions for aminoethylcysteine were established with the use of a single-column amino acid analyser equipped with a 150 x 4 mm I.D. column packed with Hitachi custom ion-exchange resin 2617 (5 μm). Using three buffer solutions twenty a